Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 31.15
+0.58 (1.90%)
Feb 3, 2026, 3:00 PM CST
SHA:688321 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 7.28 | -114.57 | 88.84 | 17.48 | 21.96 | 31.05 |
Depreciation & Amortization | 59.03 | 59.03 | 43.73 | 38.72 | 19.62 | 11.07 |
Other Amortization | 2.46 | 2.46 | 1.89 | 3.74 | 1.65 | 0.73 |
Loss (Gain) From Sale of Assets | -0 | -0 | - | 0.71 | 0.13 | 0.13 |
Asset Writedown & Restructuring Costs | 90.12 | 90.12 | 0.03 | - | - | - |
Loss (Gain) From Sale of Investments | 21.6 | 21.6 | -282.03 | -2.4 | -5.52 | -3.16 |
Provision & Write-off of Bad Debts | -2.69 | -2.69 | 4.33 | 0.55 | 0.05 | -1.17 |
Other Operating Activities | -118.76 | 17.73 | -22.07 | 11 | 2.12 | -9.61 |
Change in Accounts Receivable | -19.62 | -19.62 | -59.12 | -42.46 | -73.72 | 50.22 |
Change in Inventory | 6.29 | 6.29 | -18.66 | -19.41 | -1.1 | -1.42 |
Change in Accounts Payable | 3.08 | 3.08 | 49.75 | 42.64 | 182.88 | 20.37 |
Change in Other Net Operating Assets | -3.37 | -3.37 | -10.02 | -4.64 | -4.59 | -2.94 |
Operating Cash Flow | 61.49 | 76.13 | -157.27 | 43.3 | 124.78 | 93.62 |
Operating Cash Flow Growth | 109.82% | - | - | -65.30% | 33.29% | - |
Capital Expenditures | -172.07 | -268.49 | -229.03 | -400.17 | -288.46 | -336.27 |
Sale of Property, Plant & Equipment | 0.02 | 0 | 0.45 | 0.29 | 0.01 | 0.01 |
Divestitures | - | - | -41.35 | - | - | - |
Investment in Securities | -8.92 | -40.47 | -119.14 | -407.46 | 245.55 | 206.71 |
Other Investing Activities | 16.03 | 12.92 | 14.06 | 5.63 | 12.28 | 20.86 |
Investing Cash Flow | -164.95 | -296.03 | -375.01 | -801.7 | -30.62 | -108.69 |
Long-Term Debt Issued | - | 408.19 | 444.21 | 541 | 174.92 | 25.04 |
Long-Term Debt Repaid | - | -190.19 | -221.73 | -260.34 | -96.55 | -67.14 |
Net Debt Issued (Repaid) | 242.32 | 217.99 | 222.48 | 280.66 | 78.37 | -42.1 |
Issuance of Common Stock | - | - | 178.88 | 488.34 | 18.01 | - |
Repurchase of Common Stock | -15 | -15 | - | - | -154.59 | - |
Common Dividends Paid | -34.67 | -27.63 | -18.74 | -12.17 | -4.22 | -3.28 |
Other Financing Activities | 14.54 | - | - | 104.46 | -0.89 | - |
Financing Cash Flow | 207.19 | 175.36 | 382.62 | 861.29 | -63.31 | -45.38 |
Foreign Exchange Rate Adjustments | -1.04 | 0.39 | 1.08 | 12.23 | -2.25 | -4.08 |
Net Cash Flow | 102.69 | -44.15 | -148.58 | 115.11 | 28.6 | -64.53 |
Free Cash Flow | -110.59 | -192.36 | -386.3 | -356.87 | -163.68 | -242.65 |
Free Cash Flow Margin | -13.00% | -29.24% | -73.76% | -67.34% | -38.03% | -90.05% |
Free Cash Flow Per Share | -0.27 | -0.47 | -0.95 | -0.88 | -0.40 | -0.59 |
Cash Income Tax Paid | 31.86 | 27.68 | 40.02 | -7.9 | 14.06 | 18.8 |
Levered Free Cash Flow | -97.54 | -223.51 | -507.91 | -232.05 | -292.18 | -244.93 |
Unlevered Free Cash Flow | -75.31 | -202.11 | -486.11 | -219.46 | -289.23 | -244.27 |
Change in Working Capital | 2.44 | 2.44 | 8 | -26.51 | 84.77 | 64.59 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.